Table 1.

The clinical correlation of NEDD9 expression in human lung cancer

Characteristics	n	NEDD9		P
		Low	High
Smoking
No	77	32 (41.6%)	45 (58.4%)	0.025a
Yes	98	25 (25.5%)	73 (74.5%)
Histology
ADC	121	39 (32.2%)	82 (67.8%)	0.886
SCC	54	18 (33.3%)	36 (66.7%)
Differentiation degree
High	19	12 (63.2%)	7 (36.8%)	0.001b
Moderate	104	36 (34.6%)	68 (65.4%)
Low	52	9 (17.3%)	43 (87.2%)
T classification
T1–2	146	49 (33.6%)	97 (66.4%)	0.531
T3–4	29	8 (27.6%)	21 (72.4%)
LN metastasis
Negative	90	38 (42.2%)	52 (57.8%)	0.005b
Positive	85	19 (22.4%)	66 (77.6%)
Clinical stage
I/II	102	42 (41.2%)	60 (58.8%)	0.004b
III/IV	73	15 (20.5%)	58 (79.5%)

Abbreviations: ADC, adenocarcinoma; SCC, squamous cell carcinoma; LN metastasis, lymph node metastasis; n, number.

^aP < 0.05.

^bP < 0.01.